Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
出版年份 2017 全文链接
标题
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-05-18
DOI
10.1038/s41598-017-02503-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Immunovirotherapy with measles virus strains in combination with anti–PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment
- (2016) Jayson Hardcastle et al. NEURO-ONCOLOGY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
- (2016) Kevin Cassady et al. Viruses-Basel
- Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
- (2015) W. Shen et al. BLOOD
- Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
- (2015) Norman Woller et al. MOLECULAR THERAPY
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
- (2015) José I. Quetglas et al. Cancer Immunology Research
- Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
- (2015) Jennifer L Leddon et al. Molecular Therapy-Oncolytics
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells
- (2011) Stefanie J. Mandl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy
- (2011) Joanna L. Meadors et al. PEDIATRIC BLOOD & CANCER
- B7-H1-Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses
- (2010) P.-Y. Lin et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started